ARCHIVES

No Evidence Of Fraud Found In NCI Audit Of NSABP Trials

This article is from The Cancer Letter archive.

Vol. 20 No. 17 | April 29, 1994

Download PDF Visit The Full Archive

Related Articles

ASTRO Issues Statement On APBI For Breast Cancer

August 28, 2009

NCAB Asks For Cost Reimbursement n Patients In Clinical Trials Until More Data Available

October 5, 1984

After ODAC: Questions On ESA Claims, Advertising, Reimbursement Gain Urgency.

May 18, 2007

ODAC To Review Taxol Nov. 16; NCI, Bristol to Discuss Pricing

October 23, 1992

Report calls for stronger peer review, prioritization for cancer clinical trials.

June 10, 2005

Expanding Umbilical Cord Stem Cells Found Safe As Standard Transplant

December 26, 2008